|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Tandem Labs To Acquire PharmaKD, A Division Of Linden Technologies Specializing In Drug Metabolite And Biomarker Profiling
9/13/2006 8:29:37 AM
SALT LAKE CITY, Sept. 13 /PRNewswire/ -- Tandem Labs (http://www.tandemlabs.com), a leading contract research organization (CRO) providing bioanalytical and immunoanalytical testing for the pharmaceutical industry, and PharmaKD (http://www.pharmakd.com/), a Boston, Massachusetts-based division of Linden Technologies providing mass spectrometry-based pharmacokinetics and pharmacodynamics (PK/PD) for drug metabolite and biomarker profiling, announced today, September 13, 2006, that Tandem Labs has acquired PharmaKD. Under the agreement, Tandem Labs will retain key personnel, intellectual property portfolios, proprietary informatics, scientific instruments, and 7,000-square-feet of operational space from PharmaKD.
|
|
|
|
|
|
|
|
|
|
|